Materials Healthcare Sector

Polarean Imaging

Market Cap: UK£14.8m

Operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States.

HOOKIPA Pharma

Market Cap: US$19.6m

A clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform.

DURECT

Market Cap: US$19.6m

A biopharmaceutical company, develops medicines based on its epigenetic regulator program.

Treatment.com AI

Market Cap: CA$27.3m

Treatment.Com International Inc. provides personalized health care information services in Canada.

BlinkLab

Market Cap: AU$30.4m

Focuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing.

Vext Science

Market Cap: CA$27.2m

Through its subsidiaries, provides integrated agricultural technology, services, and property management services in the cannabis industry in the United States.

VYNE Therapeutics

Market Cap: US$19.5m

A clinical-stage biopharmaceutical company, focuses on developing therapies to treat chronic inflammatory and immune-mediated conditions.

Jupiter Neurosciences

Market Cap: US$19.4m

A clinical stage research and development pharmaceutical company, develops resveratrol platform products for the treatment of neuroinflammation.

China SXT Pharmaceuticals

Market Cap: US$19.2m

A pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China.

BCAL Diagnostics

Market Cap: AU$30.0m

A screening and diagnostic company, engages in developing a novel blood screening test to improve the diagnosis and monitoring of breast cancer.

BioVie

Market Cap: US$19.0m

A clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease.

Poolbeg Pharma

Market Cap: UK£14.3m

Operates as a biopharmaceutical company, engages in the development and commercialization of medicines for unmet medical needs in the United Kingdom.

NKGen Biotech

Market Cap: US$18.9m

Operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies.

Passage Bio

Market Cap: US$18.8m

A genetic medicines company, develops gene therapies for central nervous system diseases.

CEL-SCI

Market Cap: US$18.8m

A clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States.

PetVivo Holdings

Market Cap: US$18.6m

A biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals.

Ananda Pharma

Market Cap: UK£14.0m

Invests in the medicinal and therapeutic cannabis market in the United Kingdom and internationally.

NEXGEL

Market Cap: US$18.4m

Manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States.

Elite Health Systems

Market Cap: US$18.4m

Through its subsidiaries, develops a business to provide Medicare Advantage plans and related services in California and Nevada.

Voyageur Pharmaceuticals

Market Cap: CA$25.7m

Engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah.

MultiCorp International

Market Cap: US$18.2m

Does not have significant operations.

Adagio Medical Holdings

Market Cap: US$18.2m

A developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias.

Third Age Health Services

Market Cap: NZ$30.9m

Provides health care services for residential aged care facilities, private hospitals, and secure dementia in New Zealand.

Gelteq

Market Cap: US$18.0m

Focuses on developing, testing, and commercializing white label gel-based delivery solutions for humans and animals in Asia-Pacific Region.

Greenway Greenhouse Cannabis

Market Cap: CA$25.1m

Engages in the cultivation, processing, and sale of dried cannabis.

Rapid Dose Therapeutics

Market Cap: CA$25.0m

A life sciences company, provides drug delivery technologies designed to enhance patient outcomes in Canada.

Aurora Spine

Market Cap: CA$24.8m

Through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada.

Allarity Therapeutics

Market Cap: US$17.7m

A clinical-stage precision medicine pharmaceutical company, focuses on developing novel anti-cancer therapeutics for patients with unmet medical needs.

VSee Health

Market Cap: US$17.5m

Provides telehealth care solutions.

DIAGNOS

Market Cap: CA$24.4m

Provides software-based services for healthcare sector in Canada, the United States, Mexico, Chile, and internationally.

TherapeuticsMD

Market Cap: US$17.4m

Operates as a pharmaceutical royalty company in the United States.

C21 Investments

Market Cap: CA$24.2m

An integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States.

SAB Biotherapeutics

Market Cap: US$17.2m

A clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders.

Devonian Health Group

Market Cap: CA$23.7m

Engages in the development of botanical drugs.

IRIDEX

Market Cap: US$17.0m

An ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology.

X4 Pharmaceuticals

Market Cap: US$16.9m

A biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system.